Research graph
References from Multi-omics in Crohn's disease: New insights from inside. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(17)32448-0
10.1016/s0140-6736(17)32448-0 · External reference
The role of environmental factors in the pathogenesis of inflammatory bowel diseases: a review
10.1001/jamapediatrics.2017.2571 · 2017 · External reference
10.1016/s0140-6736(16)31711-1
10.1016/s0140-6736(16)31711-1 · External reference
Crohn's disease
10.1038/s41572-020-0156-2 · 2020 · External reference
Preventing collateral damage in Crohn's Disease: the Lemann index
10.1093/ecco-jcc/jjv240 · 2016 · External reference
10.1016/j.mayocp.2018.09.013
10.1016/j.mayocp.2018.09.013 · External reference
10.1038/nature22969
10.1038/nature22969 · External reference
10.1038/ng.3528
10.1038/ng.3528 · External reference
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans
10.1053/j.gastro.2015.07.065 · 2015 · External reference
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
10.1136/gutjnl-2017-315866 · 2018 · External reference
10.1002/path.4817
10.1002/path.4817 · External reference
A microbial signature for Crohn's disease
10.1136/gutjnl-2016-313235 · 2017 · External reference
10.1136/gutjnl-2017-314903
10.1136/gutjnl-2017-314903 · External reference
10.1007/s00535-018-1530-7
10.1007/s00535-018-1530-7 · External reference
Biomarkers of inflammation in inflammatory bowel disease
10.1053/j.gastro.2015.07.003 · 2015 · External reference
Proteomics highlights common and distinct pathophysiological processes associated with lleal and colonic ulcers in Crohn's disease
10.1093/ecco-jcc/jjz130 · 2020 · External reference
Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011
10.1038/ajg.2015.50 · 2015 · External reference
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
10.1016/s0016-5085(03)00385-8 · 2003 · External reference
10.1002/ibd.20380
10.1002/ibd.20380 · External reference
10.1038/nature10209
10.1038/nature10209 · External reference
10.1038/35079114
10.1038/35079114 · External reference
10.1053/j.gastro.2015.08.001
10.1053/j.gastro.2015.08.001 · External reference
Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease
2010 · External reference
Association between TNF-α rs1799724 and rs1800629 polymorphisms and the risk of Crohn's disease
10.4238/2015.december.1.33 · 2015 · External reference
C3435T polymorphism of the ABCB1 gene in polish patients with inflammatory bowel disease: a case-control and meta-analysis study
10.3390/genes12091419 · 2021 · External reference
Vitamin D receptor fokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma
10.1038/s41598-018-31244-5 · 2018 · External reference
Association of fucosyltransferase 2 gene variant with inflammatory bowel diseases: a meta-analysis
10.12659/msm.911857 · 2019 · External reference
Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis
10.1038/srep18584 · 2015 · External reference
Interleukin-23R rs7517847 T/G polymorphism contributes to the risk of Crohn's disease in Caucasians: a meta-analysis
10.1155/2015/279849 · 2015 · External reference
Association between ATG16L1 gene polymorphism and the risk of Crohn's disease
10.1177/0300060516662404 · 2017 · External reference
Discs large homolog 5 (DLG5) gene polymorphism and Crohn's disease: a meta-analysis of the published studies
2016 · External reference
10.1016/j.molcel.2018.11.018
10.1016/j.molcel.2018.11.018 · External reference
10.1080/15548627.2019.1635384
10.1080/15548627.2019.1635384 · External reference
10.1159/000345129
10.1159/000345129 · External reference
10.1038/ng.762
10.1038/ng.762 · External reference
10.1136/gutjnl-2013-305193
10.1136/gutjnl-2013-305193 · External reference
10.1038/ng.3359
10.1038/ng.3359 · External reference
10.1038/nature11582
10.1038/nature11582 · External reference
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
10.1038/ng.3359 · 2015 · External reference
10.1093/ecco-jcc/jjy002
10.1093/ecco-jcc/jjy002 · External reference
10.1007/s00535-013-0866-2
10.1007/s00535-013-0866-2 · External reference
10.1093/ecco-jcc/jjab060
10.1093/ecco-jcc/jjab060 · External reference
10.1038/ng.717
10.1038/ng.717 · External reference
Mechanisms of intestinal epithelial barrier dysfunction by adherent-invasive escherichia coli
10.1016/j.jcmgh.2016.10.004 · 2017 · External reference
10.1093/ibd/izx061
10.1093/ibd/izx061 · External reference
Crohn's disease: NOD2, autophagy and ER stress converge
10.1136/gut.2009.206466 · 2011 · External reference
10.1016/j.copbio.2016.02.028
10.1016/j.copbio.2016.02.028 · External reference
NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease
10.1038/s41467-020-20348-0 · 2021 · External reference
Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study
10.1053/j.gastro.2014.12.030 · 2015 · External reference
10.1038/ng.3314
10.1038/ng.3314 · External reference
HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's disease
10.1053/j.gastro.2019.09.041 · 2020 · External reference
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
10.1038/ng.3755 · 2017 · External reference
The unsolved link of genetic markers and Crohn's disease progression: a North American Cohort experience
10.1093/ibd/izz016 · 2019 · External reference
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease
10.1038/s41598-020-58741-w · 2020 · External reference
Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases
10.1038/s41467-021-25768-0 · 2021 · External reference
A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease
10.1371/journal.pgen.1001283 · 2011 · External reference
10.1016/j.humimm.2016.07.008
10.1016/j.humimm.2016.07.008 · External reference
10.1038/ng.3538
10.1038/ng.3538 · External reference
10.1038/s41588-021-00945-5
10.1038/s41588-021-00945-5 · External reference
Molecular profiling of inflammatory bowel disease: Is it ready for use in clinical decision-making?
2019 · External reference
Genetics and phenotypes in inflammatory bowel disease
10.1016/s0140-6736(15)00464-x · 2016 · External reference
Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges
10.1371/journal.pgen.1006944 · 2017 · External reference
GWAS to the people
10.1038/s41591-018-0231-3 · 2018 · External reference
10.1038/s41467-017-01261-5
10.1038/s41467-017-01261-5 · External reference
10.1038/s41588-022-01156-2
10.1038/s41588-022-01156-2 · External reference
From genetics to epigenetics, roles of epigenetics in inflammatory bowel disease
10.3389/fgene.2019.01017 · 2019 · External reference
Genetics and epigenetics of IBD
10.1016/j.phrs.2020.104892 · 2020 · External reference
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
10.1038/s41467-020-15342-5 · 2020 · External reference
BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease
10.1172/jci140755 · 2021 · External reference
Systematic review and meta-analysis of peripheral blood DNA methylation studies in inflammatory bowel disease
2022 · External reference
Differentially expressed miRNAs in ulcerative colitis and Crohn's disease
10.3389/fimmu.2022.865777 · 2022 · External reference
MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis
2022 · External reference
Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern
10.1186/s13148-020-00843-3 · 2020 · External reference
10.1016/j.jaci.2019.11.003
10.1016/j.jaci.2019.11.003 · External reference
10.1016/j.jinf.2018.10.005
10.1016/j.jinf.2018.10.005 · External reference
The modification of the gut microbiota via selected specific diets in patients with Crohn's disease
10.3390/nu13072125 · 2021 · External reference
10.1038/s41591-018-0308-z
10.1038/s41591-018-0308-z · External reference
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study
10.1186/s40168-020-0792-5 · 2020 · External reference
Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis
10.1093/ecco-jcc/jjx063 · 2017 · External reference
Dysbiotic microbiota interactions in Crohn's disease
10.1080/19490976.2021.1949096 · 2021 · External reference
Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice
10.1186/s40168-021-01178-8 · 2021 · External reference
10.1053/j.gastro.2014.02.009
10.1053/j.gastro.2014.02.009 · External reference
10.1016/j.jmb.2018.04.009
10.1016/j.jmb.2018.04.009 · External reference
10.1128/cmr.17.4.840-862.2004
10.1128/cmr.17.4.840-862.2004 · External reference
10.1016/j.cell.2019.07.010
10.1016/j.cell.2019.07.010 · External reference
Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease
10.1186/s12876-020-01281-4 · 2020 · External reference
10.1016/j.chom.2014.02.005
10.1016/j.chom.2014.02.005 · External reference
Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease
10.3390/microorganisms9050977 · 2021 · External reference
Assessing the relationship between the gut microbiota and inflammatory bowel disease therapeutics: a systematic review
2023 · External reference
Searching for a consensus among inflammatory bowel disease studies: a systematic meta-analysis
10.1093/ibd/izac194 · 2023 · External reference
Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease
10.3390/microorganisms9050977 · 2021 · External reference
10.1007/s13238-020-00745-3
10.1007/s13238-020-00745-3 · External reference
10.1038/s41579-019-0213-6
10.1038/s41579-019-0213-6 · External reference
10.1038/nrgastro.2017.88
10.1038/nrgastro.2017.88 · External reference
Long-read metagenome-assembled genomes improve identification of novel complete biosynthetic gene clusters in a complex microbial activated sludge ecosystem
10.1128/msystems.00632-22 · 2022 · External reference
TaxiBGC: a taxonomy-guided approach for profiling experimentally characterized microbial biosynthetic gene clusters and secondary metabolite production potential in metagenomes
10.1128/msystems.00925-22 · 2022 · External reference
10.1038/s41564-021-00983-z
10.1038/s41564-021-00983-z · External reference
10.1016/j.chom.2015.09.008
10.1016/j.chom.2015.09.008 · External reference
10.1038/s41591-018-0308-z
10.1038/s41591-018-0308-z · External reference
10.1016/s0140-6736(17)30317-3
10.1016/s0140-6736(17)30317-3 · External reference
Faecalibacterium prausnitzii and human intestinal health
10.1016/j.mib.2013.06.003 · 2013 · External reference
Case-Control Study of Clostridium innocuum Infection, Taiwan
10.3201/2803.204421 · 2022 · External reference
Dysbiotic microbiota interactions in Crohn's disease
10.1080/19490976.2021.1949096 · 2021 · External reference
Effects of low FODMAP diet on symptoms, fecal Microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial
10.1053/j.gastro.2019.09.024 · 2020 · External reference
Reprocessing 16S rRNA gene amplicon sequencing studies: (Meta)data issues, robustness, and reproducibility
10.3389/fcimb.2021.720637 · 2021 · External reference
10.1016/j.csbj.2021.12.006 · Admitted local publication
Targeting RNA with Next- and Third-Generation Sequencing Improves Pathogen Identification in Clinical Samples
10.1002/advs.202102593 · 2021 · External reference
10.1038/s41575-019-0258-z
10.1038/s41575-019-0258-z · External reference
10.1093/ecco-jcc/jjaa227
10.1093/ecco-jcc/jjaa227 · External reference
10.1016/j.cmet.2016.05.005
10.1016/j.cmet.2016.05.005 · External reference
Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease
10.1080/19490976.2020.1865708 · 2021 · External reference
Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease
10.3389/fimmu.2019.02754 · 2019 · External reference
10.1016/j.csbj.2022.03.038 · Admitted local publication
Metabolomics facilitate the personalized management in inflammatory bowel disease
10.1177/17562848211064489 · 2021 · External reference
10.1146/annurev.pharmtox.48.113006.094715
10.1146/annurev.pharmtox.48.113006.094715 · External reference
10.1038/4551054a
10.1038/4551054a · External reference
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial
10.1038/ctg.2012.24 · 2013 · External reference
10.1111/1751-2980.12795
10.1111/1751-2980.12795 · External reference
10.1136/gutjnl-2013-306423
10.1136/gutjnl-2013-306423 · External reference
10.1093/ibd/izz188
10.1093/ibd/izz188 · External reference
Rapid and noninvasive metabonomic characterization of inflammatory bowel disease
10.1021/pr060470d · 2007 · External reference
10.1053/j.gastro.2022.05.050
10.1053/j.gastro.2022.05.050 · External reference
10.1038/s41586-019-1237-9
10.1038/s41586-019-1237-9 · External reference
10.1194/jlr.r500013-jlr200
10.1194/jlr.r500013-jlr200 · External reference
Serum bile acids profiling in inflammatory bowel disease patients treated with anti-TNFs
10.3390/cells8080817 · 2019 · External reference
10.1093/ecco-jcc/jjaa039
10.1093/ecco-jcc/jjaa039 · External reference
10.1038/s41586-019-1785-z
10.1038/s41586-019-1785-z · External reference
10.1038/s41586-019-1865-0
10.1038/s41586-019-1865-0 · External reference
10.1016/j.chom.2021.04.004
10.1016/j.chom.2021.04.004 · External reference
10.1111/apt.13333
10.1111/apt.13333 · External reference
Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the colonic mucosa?
10.3390/nu9030310 · 2017 · External reference
10.3390/nu9090920
10.3390/nu9090920 · External reference
Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study
10.1016/j.mri.2008.05.014 · 2009 · External reference
Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease
10.1038/s41598-020-75306-z · 2020 · External reference
10.1053/j.gastro.2017.08.028
10.1053/j.gastro.2017.08.028 · External reference
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
10.3748/wjg.v20.i1.163 · 2014 · External reference
1H NMR based metabolic profiling in Crohn's disease by random forest methodology
10.1002/mrc.4074 · 2014 · External reference
Targeted proteomics for studying pathogenic bacteria
10.1002/pmic.201800435 · 2019 · External reference
Proteomics identifies a novel role of fibrinogen-like protein 1 in Crohn's disease
10.3748/wjg.v27.i35.5946 · 2021 · External reference
10.1093/ibd/izaa352
10.1093/ibd/izaa352 · External reference
Contribution of extracellular matrix and signal mechanotransduction to epithelial cell damage in inflammatory bowel disease patients: a proteomic study
10.1002/pmic.201700164 · 2017 · External reference
High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
10.1093/ecco-jcc/jjy190 · 2019 · External reference
The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
10.1177/1756284818822250 · 2019 · External reference
Fecal biomarkers in inflammatory bowel disease
10.1111/jgh.13611 · 2017 · External reference
10.1053/j.gastro.2020.03.007
10.1053/j.gastro.2020.03.007 · External reference
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study
2020 · External reference
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity
2022 · External reference
Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with Inflammatory Bowel Disease
2022 · External reference
Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis
10.1016/j.jprot.2019.04.009 · 2019 · External reference
Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma: A pilot study
10.1097/md.0000000000018304 · 2019 · External reference
Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis
10.1080/17474124.2020.1785870 · 2020 · External reference
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease
10.1002/prca.201900110 · 2020 · External reference
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease
10.14309/ajg.0000000000000237 · 2019 · External reference
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease
10.1111/apt.16136 · 2021 · External reference
10.1053/j.gastro.2018.01.002
10.1053/j.gastro.2018.01.002 · External reference
Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease
10.1038/s41467-018-05357-4 · 2018 · External reference
Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis
10.1093/ecco-jcc/jjab061 · 2021 · External reference
Anemoside B4 ameliorates TNBS-induced colitis through S100A9/MAPK/NF-κB signaling pathway
10.1186/s13020-020-00410-1 · 2021 · External reference
10.1016/j.jcmgh.2022.06.011
10.1016/j.jcmgh.2022.06.011 · External reference
Integrated Omics: Tools, Advances, and Future Approaches
2018 · External reference
10.1038/nrg.2018.4
10.1038/nrg.2018.4 · External reference
10.1016/j.immuni.2021.07.004
10.1016/j.immuni.2021.07.004 · External reference
Integrated microbiota and metabolite profiles link Crohn's disease to sulfur metabolism
10.1038/s41467-020-17956-1 · 2020 · External reference
Location-specific signatures of Crohn's disease at a multi-omics scale
10.1186/s40168-022-01331-x · 2022 · External reference
Advancing functional and translational microbiome research using meta-omics approaches
10.1186/s40168-019-0767-6 · 2019 · External reference
10.1016/j.phrs.2021.105570
10.1016/j.phrs.2021.105570 · External reference
10.1038/ng.3936
10.1038/ng.3936 · External reference
10.1053/j.gastro.2017.10.007
10.1053/j.gastro.2017.10.007 · External reference
10.1038/s41586-019-1237-9
10.1038/s41586-019-1237-9 · External reference
Host-microbiome protein-protein interactions capture disease-relevant pathways
10.1186/s13059-022-02643-9 · 2022 · External reference
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships
10.1186/2049-2618-1-17 · 2013 · External reference
10.1080/19490976.2015.1023494
10.1080/19490976.2015.1023494 · External reference
Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation
10.1128/msystems.00013-15 · 2016 · External reference
MUSiCC: a marker genes based framework for metagenomic normalization and accurate profiling of gene abundances in the microbiome
10.1186/s13059-015-0610-8 · 2015 · External reference
10.1016/j.immuni.2014.05.015
10.1016/j.immuni.2014.05.015 · External reference
Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
10.1038/s41467-019-10927-1 · 2019 · External reference
10.1371/journal.pone.0049138
10.1371/journal.pone.0049138 · External reference
Metabolomics reveals metabolic biomarkers of Crohn's disease
10.1371/journal.pone.0006386 · 2009 · External reference
The specific carbohydrate diet and diet modification as induction therapy for pediatric Crohn's disease: a randomized diet controlled trial
10.3390/nu12123749 · 2020 · External reference
10.1016/j.chom.2021.06.019
10.1016/j.chom.2021.06.019 · External reference
Data integration and predictive modeling methods for multi-omics datasets
10.1039/c7mo00051k · 2018 · External reference
10.1016/j.compbiolchem.2019.107120
10.1016/j.compbiolchem.2019.107120 · External reference
Approaches to computational strain design in the multiomics era
10.3389/fmicb.2019.00597 · 2019 · External reference
Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
10.1186/s13073-022-01099-7 · 2022 · External reference
Multi 'omics analysis of intestinal tissue in ankylosing Spondylitis identifies alterations in the tryptophan metabolism pathway
10.3389/fimmu.2021.587119 · 2021 · External reference
An integrated genomic and transcriptomic analysis reveals candidates of susceptibility genes for Crohn's disease in japanese populations
10.1038/s41598-020-66951-5 · 2020 · External reference
The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease
10.1038/s41396-019-0560-3 · 2020 · External reference
Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease
10.1016/j.clnu.2020.04.012 · 2020 · External reference
Multi-"-omics" profiling in patients with quiescent inflammatory bowel disease identifies biomarkers predicting relapse
10.1093/ibd/izaa183 · 2020 · External reference
10.1038/s41564-018-0306-4
10.1038/s41564-018-0306-4 · External reference
The genetics universe of Crohn's disease and ulcerative colitis
10.1159/000341130 · 2012 · External reference
10.1038/s41576-019-0127-1
10.1038/s41576-019-0127-1 · External reference
10.1093/bfgp/elr009
10.1093/bfgp/elr009 · External reference
Epigenome-wide association study (EWAS) of blood lipids in healthy population from STANISLAS family study (SFS)
2019 · External reference
10.1002/em.21762
10.1002/em.21762 · External reference
Diversity in EWAS: current state, challenges, and solutions
10.1186/s13073-022-01065-3 · 2022 · External reference
Advances in epigenome-wide association studies for common diseases
10.1016/j.molmed.2014.07.002 · 2014 · External reference
Combining 16S rRNA gene variable regions enables high-resolution microbial community profiling
10.1186/s40168-017-0396-x · 2018 · External reference
10.1038/nbt.3935
10.1038/nbt.3935 · External reference
Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing in the Study of Human Gut Microbiome
10.1089/omi.2018.0013 · 2018 · External reference
10.1038/s41592-022-01726-6
10.1038/s41592-022-01726-6 · External reference
10.1093/bib/bbx170
10.1093/bib/bbx170 · External reference
10.1152/physrev.00035.2018
10.1152/physrev.00035.2018 · External reference
10.2337/db14-0509
10.2337/db14-0509 · External reference
10.1038/s41467-017-00249-5
10.1038/s41467-017-00249-5 · External reference
SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications
2017 · External reference
Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis
10.1074/mcp.o111.016717 · 2012 · External reference
Multiplexed data independent acquisition (MSX-DIA) applied by high resolution mass spectrometry improves quantification quality for the analysis of histone peptides
10.1002/pmic.201500527 · 2016 · External reference
10.1007/978-1-4939-7057-5_23
10.1007/978-1-4939-7057-5_23 · External reference
10.1002/pmic.201000553
10.1002/pmic.201000553 · External reference
